Predictors of Clinical Outcomes in Adult Laryngotracheal Stenosis

Abstract

ObjectivesSequelae of laryngotracheal stenosis (LTS) can be devastating, often necessitating tracheostomy. This study aims to describe the characteristics and outcomes of patients with LTS and identify risk factors for long‐term tracheostomy dependence stratified by etiology.MethodsA retrospective chart review was performed on 215 patients diagnosed with LTS from 09/01/2011 to 12/31/2020. Patients were grouped based on the cause of LTS. Patient factors were compared to evaluate risk factors for long‐term tracheostomy dependence.ResultsOf the 215 patients, 129 (60%) were classified as iatrogenic, 41 (19%) idiopathic, 10 (4.7%) cancer treatment, 18 (8.3%) autoimmune, and 17 (8%) patients unknown. Idiopathic patients were significantly less likely to be tracheostomy‐dependent compared with iatrogenic patients (p < 0.001) and cancer patients (p < 0.05). The mortality rate did not significantly differ among the categories (p = 0.1078). Significant improvement was seen after treatment, as the median percent of stenosis at presentation was 52.5%, and the median percent of stenosis at the most recent visit was 10% (p < 0.001). The autoimmune group received the most steroid injections (mean = 6.56; SD = 11.96). The idiopathic group had the longest surgery‐free interval (mean = 30.8 months; SD = 27.7).ConclusionIatrogenic and cancer patients were more likely to be tracheostomy‐dependent. There was a significant improvement in percent and length of stenosis after treatment, with the idiopathic group having the longest surgery‐free interval. Mortality risk did not differ among the different etiologies of LTS.Level of Evidence3 Laryngoscope, 134:257–263, 2024